O'Day SJ - Search Results

1

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

Taback B, Morton DL, O'Day SJ, Nguyen DH, Nakayama T, Hoon DS. Taback B, et al. Recent Results Cancer Res. 2001;158:78-92. doi: 10.1007/978-3-642-59537-0_8. Recent Results Cancer Res. 2001. PMID: 11092035 Review.

2

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications.

Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, Essner R, Zelman V, Yu C, Luxton G, Apuzzo ML. Lavine SD, et al. Neurosurgery. 1999 Jan;44(1):59-64; discussion 64-6. doi: 10.1097/00006123-199901000-00031. Neurosurgery. 1999. PMID: 9894964

3

Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.

O'Day SJ, Gammon G, Boasberg PD, Martin MA, Kristedja TS, Guo M, Stern S, Edwards S, Fournier P, Weisberg M, Cannon M, Fawzy NW, Johnson TD, Essner R, Foshag LJ, Morton DL. O'Day SJ, et al. J Clin Oncol. 1999 Sep;17(9):2752-61. doi: 10.1200/JCO.1999.17.9.2752. J Clin Oncol. 1999. PMID: 10561350

4

Stereotactic radiosurgery in the treatment of metastatic disease to the brain.

Chen JC, O'Day S, Morton D, Essner R, Cohen-Gadol A, MacPherson D, Giannotta SL, Petrovich Z, Yu C, Apuzzo ML. Chen JC, et al. Stereotact Funct Neurosurg. 1999;73(1-4):60-3. doi: 10.1159/000029752. Stereotact Funct Neurosurg. 1999. PMID: 10853099

5

Stereotactic radiosurgery in the treatment of metastatic disease to the brain.

Chen JC, Petrovich Z, O'Day S, Morton D, Essner R, Giannotta SL, Yu C, Apuzzo ML. Chen JC, et al. Neurosurgery. 2000 Aug;47(2):268-79; discussion 279-81. doi: 10.1097/00006123-200008000-00003. Neurosurgery. 2000. PMID: 10942000

6

Interleukin-2 binds to ganglioside GD(1b).

Ravindranath MH, Gonzales A, Soh D, Nishimoto K, Tam WY, Bilchik A, Morton DL, O'Day S. Ravindranath MH, et al. Biochem Biophys Res Commun. 2001 May 4;283(2):369-73. doi: 10.1006/bbrc.2001.4797. Biochem Biophys Res Commun. 2001. PMID: 11327710

7

High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.

O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P, Cabot M, DeGregorio MW, Gammon G. O'Day SJ, et al. Cancer. 2001 Aug 1;92(3):609-19. doi: 10.1002/1097-0142(20010801)92:3<609::aid-cncr1361>3.0.co;2-u. Cancer. 2001. PMID: 11505406 Clinical Trial.

8

Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients.

Hoon DS, Kuo CT, Wascher RA, Fournier P, Wang HJ, O'Day SJ. Hoon DS, et al. J Invest Dermatol. 2001 Aug;117(2):375-8. doi: 10.1046/j.0022-202x.2001.01417.x. J Invest Dermatol. 2001. PMID: 11511319 Free article.

9

Metastatic melanoma: chemotherapy to biochemotherapy.

O'Day SJ, Kim CJ, Reintgen DS. O'Day SJ, et al. Cancer Control. 2002 Jan-Feb;9(1):31-8. doi: 10.1177/107327480200900105. Cancer Control. 2002. PMID: 11907464 Free article. Review.

10

Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine.

DiFronzo LA, Gupta RK, Essner R, Foshag LJ, O'Day SJ, Wanek LA, Stern SL, Morton DL. DiFronzo LA, et al. J Clin Oncol. 2002 Aug 1;20(15):3242-8. doi: 10.1200/JCO.2002.01.065. J Clin Oncol. 2002. PMID: 12149297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters